10
Participants
Start Date
May 31, 2013
Primary Completion Date
September 30, 2015
Study Completion Date
September 30, 2015
18F-RGD-PET-CT and perfusion CT scans on 3 occasions
"Fluciclatide (GE Healthcare) (AH111585) is a small cyclic peptide containing the RGD tripeptide (figure 1), which preferentially binds with high affinity to α¬vβ3 integrins that are up-regulated in angiogenesis.~The IMP is supplied as a solution for injection, 400 MBq at the reference date and time. Participants will receive one injection of the imaging agent at this dose on 3 occasions"
Department of Radiology, Oxford University Hospitals NHS Trust, Oxford
Collaborators (1)
GE Healthcare
INDUSTRY
University of Oxford
OTHER
Oxford University Hospitals NHS Trust
OTHER